PuraMed BioScience Announces Completion of a Clinical Study of LipiGesic(TM) M

SCHOFIELD, Wis., July 6, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), announced today that a clinical study of LipiGesic™ M has been completed.

MORE ON THIS TOPIC